Fluame Tablet (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose appropriately according to age and symptoms.

This drug may cause gastrointestinal bleeding in individuals who regularly consume more than three glasses of alcohol daily, so it is essential to consult a doctor or pharmacist. This medication may affect the cardiovascular system, increasing the risk of myocardial infarction or stroke; therefore, individuals with cardiovascular diseases or risk factors need to exercise greater caution. There is a risk of gastrointestinal issues, such as bleeding, ulcers, or perforation in the stomach or intestines, so elderly individuals or those with a history of gastrointestinal disease should be especially careful. Individuals with a history of peptic ulcers or allergic reactions to this medication, those who are hypersensitive to aspirin or other non-steroidal anti-inflammatory drugs, and those with severe liver, kidney, or heart diseases, as well as pregnant or breastfeeding women, or individuals with specific genetic lactose issues should not take this medication. Individuals with slightly impaired liver or kidney function, the elderly, those taking diuretics, and those allergic to any dye included in this medication should use it with caution. During the course of treatment, various adverse reactions may occur, such as nausea, vomiting, diarrhea, abdominal pain, rash, shortness of breath, dizziness, or heart issues, so if these symptoms appear, immediate notification of medical staff is required. This medication should be used for the shortest duration possible at the minimal effective dose, and regular blood tests, as well as liver and kidney function tests, are necessary for long-term use. There may be interactions when combined with other anti-inflammatory drugs or specific medications, so information about other drugs being taken must be provided. During pregnancy, especially in the late stages, it may pose risks to the fetus, so it should not be taken; it is advisable to discontinue breastfeeding or medication if safety has not been established during lactation. Children under 12 years old should not take this medication, and the elderly should take it with caution at a lower dose and be aware of adverse reactions. Lastly, this medication should be kept out of reach of children, and it is advisable not to transfer it to another container.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, nausea, vomiting, photosensitivity, asthma attacks, generalized fatigue due to hypotension, hypersensitivity shock, diarrhea, abdominal distension, constipation, dyspepsia, aphthous stomatitis, abdominal pain, hematemesis, colitis, exacerbation of Crohn's disease, elevated blood pressure, tachycardia, chest pain, arrhythmia, palpitations, hypotension, congestive heart failure, edema, hypertension, heart failure, vesicular reactions, Stevens-Johnson syndrome, Lyell's syndrome, rash, urticaria, itching, purpura, dizziness, acute renal failure, interstitial nephritis, nephrotic syndrome, fluoride toxicity, abnormal liver tests, thrombocytopenia

This medication should be stored in a tightly closed container to prevent air ingress, and it is recommended to store it at room temperature between 1 degree and 30 degrees. Storing it this way will help maintain its effectiveness and prevent deterioration.

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle